Diagnosis and treatment of dementia related disorders in the era of anti-Amyloid antibody therapies

Key Points

• To evaluate the role of anti-amyloid antibody therapies in diagnosing and treating dementia-related disorders.
• Analyzed the impact of amyloid accumulation on nerve degeneration in Alzheimer’s disease.
• Discussed the use of anti-amyloid drugs like lecanemab and donanemab.
• Reviewed treatment responses in patients with mild cognitive impairment and mild dementia.
• Anti-amyloid therapies show potential in modifying disease progression in Alzheimer’s patients.
• Lecanemab and donanemab are effective for patients with mild cognitive impairment due to Alzheimer’s.
• Therapies are anticipated to improve patient outcomes significantly.